Pacira BioSciences
PCRX
PCRX
239 hedge funds and large institutions have $772M invested in Pacira BioSciences in 2024 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 87 increasing their positions, 69 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
46% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 87
48% less capital invested
Capital invested by funds: $1.48B → $772M (-$713M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
239
Holding in Top 10
1
Calls
$6.72M
Puts
$5.74M
Top Buyers
| 1 | +$42.1M | |
| 2 | +$22.2M | |
| 3 | +$16.5M | |
| 4 |
Morgan Stanley
New York
|
+$16.2M |
| 5 |
DPCM
Doma Perpetual Capital Management
Miami,
Florida
|
+$11.2M |
Top Sellers
| 1 | -$52.6M | |
| 2 | -$44.8M | |
| 3 | -$39.2M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$23.1M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$17.6M |